Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide DR formulations in IBS-C
NCT02559206Phase 2Completed
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Oct 2015
- Primary completion
- Sep 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of linaclotide in irritable bowel syndrome (IBS), sponsored by Ironwood Pharmaceuticals. Started Oct 2015; status: completed.
02
Drugs
linaclotide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02559206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02559206.